RS
Randall Stanicky RBC Capital Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
AbbVie
ABBV
$372B
| $210.42 | $135 |
36%
downside
| Outperform |
4 Feb ‘21
4 years ago |
|
2
Perrigo
PRGO
$3.07B
| $22.28 | $49 |
120%
upside
| Sector Perform |
6 Jan ‘21
4 years ago |
|
3
Pfizer
PFE
$140B
| $24.71 | $42 |
70%
upside
| Sector Perform |
16 Dec ‘20
4 years ago |
|
4
Jazz Pharmaceuticals
JAZZ
$7.88B
| $128.53 | $180 |
40%
upside
| Outperform |
3 Nov ‘20
4 years ago |
|
5
Merck
MRK
$211B
| $84.61 | $89 |
5%
upside
| Sector Perform |
1 Apr ‘20
5 years ago |
|
6
Viatris
VTRS
$12.2B
| $10.45 | $26 |
149%
upside
| Outperform |
27 Mar ‘20
5 years ago |
|
7
Amneal Pharmaceuticals
AMRX
$3.06B
| $9.89 | $4 |
60%
downside
| Sector Perform |
2 Jan ‘20
5 years ago |
|